NSE ScannerOpen the scanner

SBI Mutual Fund · Equity · Flexi Cap · Direct plan

SBI FLEXICAP FUND - Direct Plan - Growth

₹116.2461NAV on 31 Oct 2026Expense ratio 1.24%
30 Oct 2025NAV low 109.15 · high 127.96-7.8%

In plain words

Over 3 years it returned +8.2% a year, against +7.4% for its benchmark index.

Its worst fall from a peak in the last 3 years was -16.0%.

On 3-year return it ranks 35 of 36 funds in Flexi Cap.

A monthly SIP over 10 years ended ₹1,08,765 higher in the direct plan than the regular plan, because of the lower expense ratio.

Past returns, not a promise of future returns or a recommendation.

Returns vs benchmark

PeriodFundBenchmark
1 month-1.8%+1.9%
3 months-4.4%-5.1%
6 months-1.7%-3.2%
1 year-7.2%-10.2%
3 years (yearly)+8.2%+7.4%
5 years (yearly)+6.9%+6.5%
10 years (yearly)+11.4%+11.3%
Since start (yearly)+14.0%+11.2%

Monthly SIP of ₹10,000

PeriodInvestedValue nowYearly return
1 year₹1,20,000₹1,14,580-7.3%
3 years₹3,60,000₹3,63,621+0.6%
5 years₹5,90,000₹6,84,234+5.8%
10 years₹11,90,000₹20,72,489+10.6%

Top holdings (30 Sept 2026)

Fund size ₹22,109 crore · 66 holdings · 97% in equity

CompanyIndustryWeight
ICICI Bank Ltd.Banks6.90%
HDFC Bank Ltd.Banks6.24%
Larsen & Toubro Ltd.Construction3.32%
Aurobindo Pharma Ltd.Pharmaceuticals & Biotechnology3.03%
JSW Infrastructure Ltd.Transport Infrastructure2.81%
Bajaj Auto Ltd.Automobiles2.65%
Bajaj Finance Ltd.Finance2.50%
Eicher Motors Ltd.Automobiles2.46%
Titan Company Ltd.Consumer Durables2.41%
Life Insurance Corporation of IndiaInsurance2.20%
State Bank of IndiaBanks2.17%
Alphabet Inc.IT - Software2.13%
Sun Pharmaceutical Industries Ltd.Pharmaceuticals & Biotechnology2.10%
Apollo Hospitals Enterprise Ltd.Healthcare Services2.09%
Urban Company Ltd.Retailing2.07%

Largest industries: Banks 23.7%, Pharmaceuticals & Biotechnology 9.1%, Retailing 5.7%, Automobiles 5.1%, Finance 4.5%, Industrial Products 4.4%.

Other plan of this fund: SBI FLEXICAP FUND - Regular Plan - Growth

Share on WhatsAppShare on Telegram